| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9de32f6289dcf304fcf935f042feceae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bceed1cf941f453f1fb7c48d07b6cfe4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39591
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-10 |
| filingDate |
2018-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33570b587ff239354f823ddaeaf90277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b53a341274fa35f6f743d2d42683ca0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c5e01656ec23849d7a89792ed6996f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1322266ead5f47d8ac0fd47b0497ec45 |
| publicationDate |
2019-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019108689-A1 |
| titleOfInvention |
Lyophilized formulation of a monoclonal antibody against transthyretin |
| abstract |
The invention provides antibody formulations and methods useful for prophylaxis or treatment of transthyretin-related amyloidosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10669330-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11028158-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021228987-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11629185-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023099788-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11267878-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11267877-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10906967-B2 |
| priorityDate |
2017-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |